+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Anxiety Disorders - Market Analysis, Trends, and Forecasts

  • ID: 1824120
  • Report
  • 151 Pages
  • Global Industry Analysts, Inc
1 of 3

FEATURED COMPANIES

  • Abbott Laboratories
  • Allergan Plc
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ag
  • Glaxosmithkline Plc
  • Pfizer, Inc
  • MORE
The Anxiety Disorders market worldwide is projected to grow by US$1.3 Billion, driven by a compounded growth of 2.7%. Antidepressants, one of the segments analyzed and sized in this study, displays the potential to grow at over 3%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$3.6 Billion by the year 2025, Antidepressants will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 2.1% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$49.7 Million to the region's size and clout in the next 5 to 6 years. Over US$37.3 Million worth of projected demand in the region will come from the rest of the European markets. In Japan, Antidepressants will reach a market size of US$204.6 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 4.3% over the next couple of years and add approximately US$371.7 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders.

Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include:
  • Abbott Laboratories, Inc.
  • Allergan PLC
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline PLC
  • Noven Pharmaceuticals, Inc.
  • Pfizer, Inc.
  • Shionogi & Co., Ltd.
  • Sumitomo Dainippon Pharma Co., Ltd.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott Laboratories
  • Allergan Plc
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ag
  • Glaxosmithkline Plc
  • Pfizer, Inc
  • MORE

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Global Competitor Market Shares

Anxiety Disorders Competitor Market Share Scenario Worldwide (in %): 2019 & 2028

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

TABLE 1: Anxiety Disorders Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 2: Anxiety Disorders Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017

TABLE 3: Anxiety Disorders Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025

TABLE 4: Antidepressants (Therapeutic Type) World Market by Region/Country in US$ Million: 2018 to 2025

TABLE 5: Antidepressants (Therapeutic Type) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017

TABLE 6: Antidepressants (Therapeutic Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025

TABLE 7: Benzodiazepines (Therapeutic Type) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025

TABLE 8: Benzodiazepines (Therapeutic Type) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017

TABLE 9: Benzodiazepines (Therapeutic Type) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025

TABLE 10: Other Therapeutic Types (Therapeutic Type) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025

TABLE 11: Other Therapeutic Types (Therapeutic Type) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017

TABLE 12: Other Therapeutic Types (Therapeutic Type) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES

Market Facts & Figures

US Anxiety Disorders Market Share (in %) by Company: 2019 & 2025

TABLE 13: United States Anxiety Disorders Market Estimates and Projections in US$ Million by Therapeutic Type: 2018 to 2025

TABLE 14: Anxiety Disorders Market in the United States by Therapeutic Type: A Historic Review in US$ Million for 2009-2017

TABLE 15: United States Anxiety Disorders Market Share Breakdown by Therapeutic Type: 2009 VS 2019 VS 2025

CANADA

TABLE 16: Canadian Anxiety Disorders Market Estimates and Forecasts in US$ Million by Therapeutic Type: 2018 to 2025

TABLE 17: Canadian Anxiety Disorders Historic Market Review by Therapeutic Type in US$ Million: 2009-2017

TABLE 18: Anxiety Disorders Market in Canada: Percentage Share Breakdown of Sales by Therapeutic Type for 2009, 2019, and 2025

JAPAN

TABLE 19: Japanese Market for Anxiety Disorders: Annual Sales Estimates and Projections in US$ Million by Therapeutic Type for the Period 2018-2025

TABLE 20: Anxiety Disorders Market in Japan: Historic Sales Analysis in US$ Million by Therapeutic Type for the Period 2009-2017

TABLE 21: Japanese Anxiety Disorders Market Share Analysis by Therapeutic Type: 2009 VS 2019 VS 2025

CHINA

TABLE 22: Chinese Anxiety Disorders Market Growth Prospects in US$ Million by Therapeutic Type for the Period 2018-2025

TABLE 23: Anxiety Disorders Historic Market Analysis in China in US$ Million by Therapeutic Type: 2009-2017

TABLE 24: Chinese Anxiety Disorders Market by Therapeutic Type: Percentage Breakdown of Sales for 2009, 2019, and 2025

EUROPE

Market Facts & Figures

European Anxiety Disorders Market: Competitor Market Share Scenario (in %) for 2019 & 2025

TABLE 25: European Anxiety Disorders Market Demand Scenario in US$ Million by Region/Country: 2018-2025

TABLE 26: Anxiety Disorders Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017

TABLE 27: European Anxiety Disorders Market Share Shift by Region/Country: 2009 VS 2019 VS 2025

TABLE 28: European Anxiety Disorders Market Estimates and Forecasts in US$ Million by Therapeutic Type: 2018-2025

TABLE 29: Anxiety Disorders Market in Europe in US$ Million by Therapeutic Type: A Historic Review for the Period 2009-2017

TABLE 30: European Anxiety Disorders Market Share Breakdown by Therapeutic Type: 2009 VS 2019 VS 2025

FRANCE

TABLE 31: Anxiety Disorders Market in France by Therapeutic Type: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 32: French Anxiety Disorders Historic Market Scenario in US$ Million by Therapeutic Type: 2009-2017

TABLE 33: French Anxiety Disorders Market Share Analysis by Therapeutic Type: 2009 VS 2019 VS 2025

GERMANY

TABLE 34: Anxiety Disorders Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Therapeutic Type for the Period 2018-2025

TABLE 35: German Anxiety Disorders Historic Market Analysis in US$ Million by Therapeutic Type: 2009-2017

TABLE 36: German Anxiety Disorders Market Share Breakdown by Therapeutic Type: 2009 VS 2019 VS 2025

ITALY

TABLE 37: Italian Anxiety Disorders Market Growth Prospects in US$ Million by Therapeutic Type for the Period 2018-2025

TABLE 38: Anxiety Disorders Historic Market Analysis in Italy in US$ Million by Therapeutic Type: 2009-2017

TABLE 39: Italian Anxiety Disorders Market by Therapeutic Type: Percentage Breakdown of Sales for 2009, 2019, and 2025

UNITED KINGDOM

TABLE 40: United Kingdom Market for Anxiety Disorders: Annual Sales Estimates and Projections in US$ Million by Therapeutic Type for the Period 2018-2025

TABLE 41: Anxiety Disorders Market in the United Kingdom: Historic Sales Analysis in US$ Million by Therapeutic Type for the Period 2009-2017

TABLE 42: United Kingdom Anxiety Disorders Market Share Analysis by Therapeutic Type: 2009 VS 2019 VS 2025

SPAIN

TABLE 43: Spanish Anxiety Disorders Market Estimates and Forecasts in US$ Million by Therapeutic Type: 2018 to 2025

TABLE 44: Spanish Anxiety Disorders Historic Market Review by Therapeutic Type in US$ Million: 2009-2017

TABLE 45: Anxiety Disorders Market in Spain: Percentage Share Breakdown of Sales by Therapeutic Type for 2009, 2019, and 2025

RUSSIA

TABLE 46: Russian Anxiety Disorders Market Estimates and Projections in US$ Million by Therapeutic Type: 2018 to 2025

TABLE 47: Anxiety Disorders Market in Russia by Therapeutic Type: A Historic Review in US$ Million for 2009-2017

TABLE 48: Russian Anxiety Disorders Market Share Breakdown by Therapeutic Type: 2009 VS 2019 VS 2025

REST OF EUROPE

TABLE 49: Rest of Europe Anxiety Disorders Market Estimates and Forecasts in US$ Million by Therapeutic Type: 2018-2025

TABLE 50: Anxiety Disorders Market in Rest of Europe in US$ Million by Therapeutic Type: A Historic Review for the Period 2009-2017

TABLE 51: Rest of Europe Anxiety Disorders Market Share Breakdown by Therapeutic Type: 2009 VS 2019 VS 2025

ASIA-PACIFIC

TABLE 52: Asia-Pacific Anxiety Disorders Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 53: Anxiety Disorders Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2009-2017

TABLE 54: Asia-Pacific Anxiety Disorders Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025

TABLE 55: Anxiety Disorders Market in Asia-Pacific by Therapeutic Type: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 56: Asia-Pacific Anxiety Disorders Historic Market Scenario in US$ Million by Therapeutic Type: 2009-2017

TABLE 57: Asia-Pacific Anxiety Disorders Market Share Analysis by Therapeutic Type: 2009 VS 2019 VS 2025

AUSTRALIA

TABLE 58: Anxiety Disorders Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Therapeutic Type for the Period 2018-2025

TABLE 59: Australian Anxiety Disorders Historic Market Analysis in US$ Million by Therapeutic Type: 2009-2017

TABLE 60: Australian Anxiety Disorders Market Share Breakdown by Therapeutic Type: 2009 VS 2019 VS 2025

INDIA

TABLE 61: Indian Anxiety Disorders Market Estimates and Forecasts in US$ Million by Therapeutic Type: 2018 to 2025

TABLE 62: Indian Anxiety Disorders Historic Market Review by Therapeutic Type in US$ Million: 2009-2017

TABLE 63: Anxiety Disorders Market in India: Percentage Share Breakdown of Sales by Therapeutic Type for 2009, 2019, and 2025

SOUTH KOREA

TABLE 64: Anxiety Disorders Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Therapeutic Type for the Period 2018-2025

TABLE 65: South Korean Anxiety Disorders Historic Market Analysis in US$ Million by Therapeutic Type: 2009-2017

TABLE 66: Anxiety Disorders Market Share Distribution in South Korea by Therapeutic Type: 2009 VS 2019 VS 2025

REST OF ASIA-PACIFIC

TABLE 67: Rest of Asia-Pacific Market for Anxiety Disorders: Annual Sales Estimates and Projections in US$ Million by Therapeutic Type for the Period 2018-2025

TABLE 68: Anxiety Disorders Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Therapeutic Type for the Period 2009-2017

TABLE 69: Rest of Asia-Pacific Anxiety Disorders Market Share Analysis by Therapeutic Type: 2009 VS 2019 VS 2025

LATIN AMERICA

TABLE 70: Latin American Anxiety Disorders Market Trends by Region/Country in US$ Million: 2018-2025

TABLE 71: Anxiety Disorders Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2009-2017

TABLE 72: Latin American Anxiety Disorders Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025

TABLE 73: Latin American Anxiety Disorders Market Growth Prospects in US$ Million by Therapeutic Type for the Period 2018-2025

TABLE 74: Anxiety Disorders Historic Market Analysis in Latin America in US$ Million by Therapeutic Type: 2009-2017

TABLE 75: Latin American Anxiety Disorders Market by Therapeutic Type: Percentage Breakdown of Sales for 2009, 2019, and 2025

ARGENTINA

TABLE 76: Argentinean Anxiety Disorders Market Estimates and Forecasts in US$ Million by Therapeutic Type: 2018-2025

TABLE 77: Anxiety Disorders Market in Argentina in US$ Million by Therapeutic Type: A Historic Review for the Period 2009-2017

TABLE 78: Argentinean Anxiety Disorders Market Share Breakdown by Therapeutic Type: 2009 VS 2019 VS 2025

BRAZIL

TABLE 79: Anxiety Disorders Market in Brazil by Therapeutic Type: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 80: Brazilian Anxiety Disorders Historic Market Scenario in US$ Million by Therapeutic Type: 2009-2017

TABLE 81: Brazilian Anxiety Disorders Market Share Analysis by Therapeutic Type: 2009 VS 2019 VS 2025

MEXICO

TABLE 82: Anxiety Disorders Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Therapeutic Type for the Period 2018-2025

TABLE 83: Mexican Anxiety Disorders Historic Market Analysis in US$ Million by Therapeutic Type: 2009-2017

TABLE 84: Mexican Anxiety Disorders Market Share Breakdown by Therapeutic Type: 2009 VS 2019 VS 2025

REST OF LATIN AMERICA

TABLE 85: Rest of Latin America Anxiety Disorders Market Estimates and Projections in US$ Million by Therapeutic Type: 2018 to 2025

TABLE 86: Anxiety Disorders Market in Rest of Latin America by Therapeutic Type: A Historic Review in US$ Million for 2009-2017

TABLE 87: Rest of Latin America Anxiety Disorders Market Share Breakdown by Therapeutic Type: 2009 VS 2019 VS 2025

MIDDLE EAST

TABLE 88: The Middle East Anxiety Disorders Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 89: Anxiety Disorders Market in the Middle East by Region/Country in US$ Million: 2009-2017

TABLE 90: The Middle East Anxiety Disorders Market Share Breakdown by Region/Country: 2009, 2019, and 2025

TABLE 91: The Middle East Anxiety Disorders Market Estimates and Forecasts in US$ Million by Therapeutic Type: 2018 to 2025

TABLE 92: The Middle East Anxiety Disorders Historic Market by Therapeutic Type in US$ Million: 2009-2017

TABLE 93: Anxiety Disorders Market in the Middle East: Percentage Share Breakdown of Sales by Therapeutic Type for 2009, 2019, and 2025

IRAN

TABLE 94: Iranian Market for Anxiety Disorders: Annual Sales Estimates and Projections in US$ Million by Therapeutic Type for the Period 2018-2025

TABLE 95: Anxiety Disorders Market in Iran: Historic Sales Analysis in US$ Million by Therapeutic Type for the Period 2009-2017

TABLE 96: Iranian Anxiety Disorders Market Share Analysis by Therapeutic Type: 2009 VS 2019 VS 2025

ISRAEL

TABLE 97: Israeli Anxiety Disorders Market Estimates and Forecasts in US$ Million by Therapeutic Type: 2018-2025

TABLE 98: Anxiety Disorders Market in Israel in US$ Million by Therapeutic Type: A Historic Review for the Period 2009-2017

TABLE 99: Israeli Anxiety Disorders Market Share Breakdown by Therapeutic Type: 2009 VS 2019 VS 2025

SAUDI ARABIA

TABLE 100: Saudi Arabian Anxiety Disorders Market Growth Prospects in US$ Million by Therapeutic Type for the Period 2018-2025

TABLE 101: Anxiety Disorders Historic Market Analysis in Saudi Arabia in US$ Million by Therapeutic Type: 2009-2017

TABLE 102: Saudi Arabian Anxiety Disorders Market by Therapeutic Type: Percentage Breakdown of Sales for 2009, 2019, and 2025

UNITED ARAB EMIRATES

TABLE 103: Anxiety Disorders Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Therapeutic Type for the Period 2018-2025

TABLE 104: United Arab Emirates Anxiety Disorders Historic Market Analysis in US$ Million by Therapeutic Type: 2009-2017

TABLE 105: Anxiety Disorders Market Share Distribution in United Arab Emirates by Therapeutic Type: 2009 VS 2019 VS 2025

REST OF MIDDLE EAST

TABLE 106: Anxiety Disorders Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Therapeutic Type for the Period 2018-2025

TABLE 107: Rest of Middle East Anxiety Disorders Historic Market Analysis in US$ Million by Therapeutic Type: 2009-2017

TABLE 108: Rest of Middle East Anxiety Disorders Market Share Breakdown by Therapeutic Type: 2009 VS 2019 VS 2025

AFRICA

TABLE 109: African Anxiety Disorders Market Estimates and Projections in US$ Million by Therapeutic Type: 2018 to 2025

TABLE 110: Anxiety Disorders Market in Africa by Therapeutic Type: A Historic Review in US$ Million for 2009-2017

TABLE 111: African Anxiety Disorders Market Share Breakdown by Therapeutic Type: 2009 VS 2019 VS 2025

IV. COMPETITION

ABBOTT LABORATORIES

ALLERGAN PLC

BRISTOL-MYERS SQUIBB COMPANY

ELI LILLY AND COMPANY

F. HOFFMANN-LA ROCHE AG

GLAXOSMITHKLINE PLC

NOVEN PHARMACEUTICALS, INC.

PFIZER, INC

SHIONOGI & CO., LTD.

SUMITOMO DAINIPPON PHARMA CO.

V. CURATED RESEARCH

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Abbott Laboratories
  • Allergan Plc
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ag
  • Glaxosmithkline Plc
  • Noven Pharmaceuticals, Inc.
  • Pfizer, Inc
  • Shionogi & Co., Ltd.
  • Sumitomo Dainippon Pharma Co.
Note: Product cover images may vary from those shown
Adroll
adroll